Arena Pharmaceuticals (ARNA) inked a deal with United Therapeutics (UTHR) to sell and develop its Phase 3 investigational drug candidate ralinepag worldwide. Under the agreement terms, Arena Pharma will receive … Continue reading Arena Pharmaceuticals soars on the $1.2 billion deal with United Therapeutics